Blair William & CO Alaunos Therapeutics, Inc. Transaction History

Blair William & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.41 - $1.24 $38,428 - $116,223	93,729 New	93,729 $116,000
Q3 2019 Nov 12, 2019	SELL	$4.13 - $6.94 $246,065 - $413,485	-59,580 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$3.98 - $6.2 $115,420 - $179,800	-29,000 Reduced 32.74%	59,580 $347,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $2,415 - $5,430	1,500 Added 1.72%	88,580 $166,000
Q2 2018 Aug 13, 2018	BUY	$3.02 - $4.94 $262,981 - $430,175	87,080 New	87,080 $263,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $422M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.